Home › Funds › ELWOOD CAPITAL PARTNERS LP › SHC
ELWOOD CAPITAL PARTNERS LP position in SHC
SOTERA HEALTH CO · Health Care
ELWOOD CAPITAL PARTNERS LP reported holding 137,500 shares of SHC (SOTERA HEALTH CO) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 1.81% of its reported portfolio and ranking #19 among its reported holdings. ELWOOD CAPITAL PARTNERS LP has disclosed SHC holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ELWOOD CAPITAL PARTNERS LP's SHC position evolved
ELWOOD CAPITAL PARTNERS LP first disclosed a stake in SHC in Q2 2026 at 187,500 shares (US$3.3M). Across 2 filings, ELWOOD CAPITAL PARTNERS LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 137,500 shares valued at US$2.5M — a reduction of -50,000 shares quarter over quarter.. Notable position changes include a 27% trim in Q3 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 187.50K | $3.33M | New |
| Q3 2026 | 137.50K | $2.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SHC and 13F data
SHC (SOTERA HEALTH CO) is a Health Care company. 45 other funds we track also report a position in SHC — the largest reported positions include Sessa Capital IM, L.P. (US$480.1M), Darsana Capital Partners LP (US$479.2M), Sculptor Capital LP (US$425.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SHC
- Sessa Capital IM, L.P. 27.05M sh · $480.14M · Q2 2026
- Darsana Capital Partners LP 27.00M sh · $479.25M · Q2 2026
- Sculptor Capital LP 23.00M sh · $425.27M · Q3 2026
- Two Seas Capital LP 6.11M sh · $112.99M · Q3 2026
- Voss Capital, LP 5.83M sh · $103.39M · Q2 2026
- Irenic Capital Management LP 5.14M sh · $91.27M · Q2 2026
- DME Capital Management, LP 4.14M sh · $73.41M · Q2 2026
- LAKEWOOD CAPITAL MANAGEMENT, LP 3.47M sh · $64.25M · Q3 2026
- ION Fund Management Ltd 3.34M sh · $59.35M · Q2 2026
- Ancora Advisors LLC 2.68M sh · $47.63M · Q2 2026
- Ananym Capital Management, LP 2.03M sh · $36.03M · Q2 2026
- Inherent Management Corp. 1.66M sh · $30.70M · Q3 2026
More on ELWOOD CAPITAL PARTNERS LP
FAQ
How long has ELWOOD CAPITAL PARTNERS LP held SHC?
ELWOOD CAPITAL PARTNERS LP has disclosed SHC holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is ELWOOD CAPITAL PARTNERS LP's current position in SHC?
As of Q3 2026, ELWOOD CAPITAL PARTNERS LP holds 137.50K shares of SHC (SOTERA HEALTH CO), valued at $2.54M, representing 1.81% of its reported portfolio and ranking #19.
Has ELWOOD CAPITAL PARTNERS LP been buying or selling SHC?
In the latest 13F filing (Q3 2026), ELWOOD CAPITAL PARTNERS LP reduced its position in SHC.
Which other funds hold SHC?
Other major institutional holders of SHC include Sessa Capital IM, L.P., Darsana Capital Partners LP, Sculptor Capital LP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.